LJHT
ATRA icon

Laurie J. Hall Trustee’s Atara Biotherapeutics ATRA Stock Holding History

Laurie J. Hall Trustee’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9
Closed -$1K – 262
2022
Q4 		$1K Hold
9
– – ﹤0.01% 293
2022
Q3 		$1K Sell
9
-5
-36% -$562 ﹤0.01% 306
2022
Q2 		$3K Hold
14
– – ﹤0.01% 295
2022
Q1 		$3K Hold
14
– – ﹤0.01% 304
2021
Q4 		$5K Hold
14
– – ﹤0.01% 299
2021
Q3 		$6K Sell
14
-8
-36% -$2.87K ﹤0.01% 291
2021
Q2 		$9K Hold
22
– – ﹤0.01% 288
2021
Q1 		$8K Hold
22
– – ﹤0.01% 294
2020
Q4 		$11K Hold
22
– – ﹤0.01% 280
2020
Q3 		$7K Buy
+22
New +$7.49K ﹤0.01% 279
2019
Q4 		$5K Buy
+11
New +$3.79K ﹤0.01% 293

Other funds holding ATRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Laurie J. Hall Trustee's ATRA Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Atara Biotherapeutics (ATRA) in Q1 2023, closing a stake of 9 shares — an estimated $1K sold.

Laurie J. Hall Trustee first reported a position in ATRA in Q4 2019 and held it in 11 quarters. The position peaked at $11K in Q4 2020. 125 funds tracked by Wall St. Rank hold ATRA as of Q1 2023.

  • Laurie J. Hall Trustee reported no remaining Atara Biotherapeutics position as of Q1 2023 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 9 Atara Biotherapeutics shares in Q1 2023, an estimated $1K.
  • Laurie J. Hall Trustee first reported a position in Atara Biotherapeutics in Q4 2019 and held it in 11 quarters.
  • Laurie J. Hall Trustee's Atara Biotherapeutics position peaked at $11K in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.